Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indacaterol 150 μg in COPD
NCT00624286Phase 3Completed
- Sponsor
- Novartis
- Start
- Feb 2008
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of indacaterol in chronic obstructive pulmonary disease (COPD), sponsored by Novartis. Started Feb 2008; status: completed.
02
Drugs
indacaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00624286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00624286.